Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Post by paperboy222on Jan 08, 2010 10:55pm
325 Views
Post# 16658240

AGM Jan 19-2010

AGM Jan 19-2010
Niogold Mining Corp., Annual General Meeting, Jan 19, 2010

Niogold Mining Corp., Annual General Meeting, Jan 19, 2010, at 10:00 US Pacific Time. Location: 1600-609 Granville Street, Vancouver, BC V7Y 1C3,Canada. Agenda: To receive and consider the Audited Financial Statements for the financial year ending August 31, 2009; to appoint Robert W.R. Bishop, Chartered Accountants, as auditor of the company to hold office until the next annual general meeting, at a remuneration to be fixed by the directors; to fix the number of directors for the ensuing year at four; to elect directors to hold office until the next annual general meeting of the company; to re-approve the company's stock option plan, as amended, as set out under the heading 'Re-Approval of Rolling Stock Option Plan' in the Information Circular; and to transact such other business as may properly be transacted at such meeting or at any adjournment thereof

Bullboard Posts